A phase II study of gemcitabine and cisplatin in patients with advanced hepatocellular carcinoma.

Tropical gastroenterology : official journal of the Digestive Diseases Foundation

Volumn 26, Issue 3, 2005, Pages 115-118

  Parikh, P M ^a   Fuloria, J ^a   Babu, G ^a   Doval, D C ^a   Awasthy, B S ^a   Pai, V R ^a   Prabhakaran, P S ^a   Benson, A B ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; DEOXYCYTIDINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33645633809     PISSN: 0250636X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)